What are the preferred antiretroviral therapy (ART) regimens for pregnant women with HIV infection?

Updated: Jul 26, 2021
  • Author: Madhu Chhanda Choudhary, MD; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print


Preferred regimens have demonstrated optimal efficacy and durability with acceptable toxicity and ease of use. No evidence of teratogenic effects on the fetus or established association with teratogenic or clinically significant adverse outcomes for the mother, fetus, or newborn are present. [1]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!